• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Gynecologic Oncology

Gynecologic Oncology

  • Contact Us
  • 888-GYNONC1

GYN 106

Advanced Ovarian Cancer: Platinum Sensitive

Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor-Alpha Expression

Cancer Types: Ovarian

Lines of Therapy: 3rd Line+ Metastatic

View Details on ClinicalTrials.gov

Back to Clinical Trials

Footer

 

To schedule an appointment:

888-GYNONC1

 

Copyright © 2025 Gynecologic Oncology